Loading...
*  Prostate Adenocarcinoma TransCutaneous Hormones - Full Text View - ClinicalTrials.gov
Prostate Adenocarcinoma TransCutaneous Hormones (PATCH). The safety and scientific validity of this study is the responsibility ... Adenocarcinoma. Osteoporosis. Hot Flashes. Genital Neoplasms, Male. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Genital ... Stage T3 or T4, NX, M0 histologically confirmed prostate adenocarcinoma with prostate-specific antigen (PSA) ≥ 20 ng/mL or ... Patients with histologically confirmed prostate adenocarcinoma previously treated with radical surgery or radiotherapy who are ...
https://clinicaltrials.gov/ct2/show/NCT00303784
*  Pancreatic Adenocarcinoma Gene Environment Risk Study - Full Text View - ClinicalTrials.gov
Pancreatic Adenocarcinoma Gene Environment Risk Study (PAGER). The safety and scientific validity of this study is the ... The Pancreatic Adenocarcinoma Gene Environment Risk Study -A Prospective Cohort Study of Patients at Risk or Having Pancreatic ... Adenocarcinoma. Pancreatic Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ... Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma. *Subjects with abnormal imaging study (CT, MRI ...
https://clinicaltrials.gov/ct2/show/NCT00912717
*  Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature - Full Text View - ClinicalTrials.gov
Pneumonic-type Adenocarcinoma (P-ADC) Lung Adenocarcinoma With Bronchiolo-alveolar Feature Drug: Gefitinib Phase 2 ... Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature. The safety and scientific validity of this study is the ... Pneumonic adenocarcinoma (P-ADC) is defined as a primary lung ADC with a radiological pneumonic presentation, usually referred ... Adenocarcinoma. Lung Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ...
https://clinicaltrials.gov/ct2/show/NCT00198380
*  Search of: 'Adenocarcinoma of lung' - Modify Search - ClinicalTrials.gov
Search of: 'Adenocarcinoma of lung' - Modify Search. Fill in any or all of the fields below. Click on the label to the left of ...
https://clinicaltrials.gov/ct2/results/refine?cond=%22Adenocarcinoma+of+lung%22
*  Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma - Full Text View - ClinicalTrials.gov
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma. The safety and scientific validity of this study is the ... Open label study using oral sorafenib 800 mg daily in any stage III-IV BAC lung cancer and Stage III-IV adenocarcinoma of the ... Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Sorafenib. ... A Phase II Trial of Sorafenib in BAC or Never-Smokers With Any Lung Adenocarcinoma. ...
https://clinicaltrials.gov/ct2/show/NCT00456716?cond=%22Adenocarcinoma+of+lung%22&rank=16
*  Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases - Full Text View - ClinicalTrials.gov
Lung Adenocarcinoma Brain Metastases Drug: erlotinib Drug: pemetrexed Drug: cisplatin Phase 2 ... Adenocarcinoma. Neoplasm Metastasis. Neoplasms, Second Primary. Brain Neoplasms. Lung Neoplasms. Carcinoma. Neoplasms, ... Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases. This study has been completed. ... Brain metastases are a frequent complication of NSCLC, especially in lung adenocarcinoma. 30-50% or more these patients will ...
https://clinicaltrials.gov/ct2/show/NCT01578668?cond=%22Adenocarcinoma+of+lung%22&rank=2
*  First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker - Full Text View - ClinicalTrials.gov
First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker. The safety and scientific validity of this ... Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Gemcitabine. Gefitinib ... This is a randomized, open label, parallel group, phase III study in never-smokers with advanced or metastatic adenocarcinoma ... Histologically or cytologically confirmed diagnosis of adenocarcinoma of lung with or without BAC features; however, ...
https://clinicaltrials.gov/show/NCT00455936
*  Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma - Full Text View - ClinicalTrials.gov
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma. The safety and scientific validity of ... Phase 2 hypofractionation study usion proton beam therapy for prostate adenocarcinoma. Condition or disease Intervention/ ... Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Genital Neoplasms, ... Biopsy proven prostate adenocarcinoma Stage: T1-T2cN0M0 ECOG performance status: 0-2 Signed study specific informed consent ...
https://clinicaltrials.gov/ct2/show?term=proton+beam+and+prostate&rank=3
*  Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma - Full Text View -...
Adenocarcinoma. Stomach Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ... Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma. This study has been completed ... Patients with histologically confirmed, newly diagnosed, localized gastric or gastro-esophageal adenocarcinoma, that is ... Oxaliplatin and S-1 Chemotherapy in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma.. ...
https://clinicaltrials.gov/ct2/show/NCT00816543
*  Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma - Full Text View -...
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma. The safety and ... Adenocarcinoma. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. Nivolumab. ... Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma. Actual Study Start Date ... Immunotherapy and irreversible electroporation in the treatment of advanced pancreatic adenocarcinoma. This is a Phase II study ...
https://clinicaltrials.gov/ct2/show?term=Louisville&rank=12
*  Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma - Full Text View - ClinicalTrials.gov
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma. The safety and scientific validity of this ... Adenocarcinoma. Lung Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ... in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue. ...
https://clinicaltrials.gov/ct2/show/NCT01249066?cond=%22Adenocarcinoma+of+lung%22&rank=2
*  Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma - Full Text View -...
Adenocarcinoma. Pancreatic Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ... Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma. This study is ongoing, but ... Patients must have histological proven adenocarcinoma of the pancreas with potentially resectable disease based upon clinical ... Patients with resectable pancreatic adenocarcinoma by clinical staging criteria will be eligible for enrollment. ...
https://clinicaltrials.gov/ct2/show/NCT00600002
*  Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma - Tabular View -...
Pancreatic Adenocarcinoma. Intervention ICMJE *Drug: Nivolumab Given post-operatively every two weeks for a total of 4 doses. ... Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma. The safety and ... Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma. Official Title ICMJE ... Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma. Brief Summary Compare ...
https://clinicaltrials.gov/ct2/show/record/NCT03080974?term=Louisville&rank=6
*  Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma - Full Text View - ClinicalTrials.gov
Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma (GLNE010). This study has been completed. ... Adenocarcinoma. Rectal Neoplasms. Colonic Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic ... Validation and Comparison of Biomarkers for the Early Detection of Colorectal Adenocarcinoma. ... Stage , 0, I or Ia Grade 1 adenocarcinoma of the endometrium treated with surgery ...
https://clinicaltrials.gov/ct2/show/NCT01511653?term=edrn&rank=2
*  Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach - Full Text View - ClinicalTrials.gov
Adenocarcinoma of the Stomach Adenocarcinoma of the Gastroesophageal Junction Drug: Irinotecan, Leucovorin, 5-Fluorouracil, ... Gastroesophageal junction adenocarcinoma extending to the stomach with the center lying 2 to 5 cm below the anatomic esophago- ... Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S). This study has been completed. ... Adenocarcinoma. Esophageal Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ...
https://clinicaltrials.gov/ct2/show/NCT01640782
*  Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma - Full Text View -...
Adenocarcinoma. Esophageal Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Neoplasms. ... Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma. This study is ongoing, but ... Subject must have unresectable or metastatic gastroesophageal adenocarcinoma.. *Subject must have evaluable disease as per ... Subject with previously untreated unresectable or metastatic gastroesophageal adenocarcinoma.. *Subject with more than 2 prior ...
https://clinicaltrials.gov/ct2/show/NCT01757171
*  Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma - Full Text View - ClinicalTrials.gov
Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma (SYSTHER). The safety and scientific ... Interventional study of modulation of immune response in patients with pancreatic tubular adenocarcinoma after resection and ... Following R0 or R1 pancreatic tubular adenocarcinoma resection and adjuvant gemcitabine treatment ...
https://clinicaltrials.gov/ct2/show/NCT01021800
*  Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal...
Adenocarcinoma. Kidney Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Kidney Diseases. Urologic ...
https://clinicaltrials.gov/ct2/show/NCT01339962
*  Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer - Full Text View - ClinicalTrials.gov
Background:. The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the laboratory in large numbers, and then giving the cells back to the patient. These cells are called Tumor Infiltrating Lymphocytes, or TIL and we have given this type of treatment to over 200 patients with melanoma. Researchers want to know if TIL shrink s tumors in people with digestive tract, urothelial, breast, or ovarian/endometrial cancers. In this study, we are selecting a specific subset of white blood cells from the tumor that we think are the most effective in fighting tumors and will use only these cells in making the tumor fighting cells.. Objective:. The purpose of this study is to see if these specifically selected tumor fighting cells can cause digestive tract, urothelial, breast, or ovarian/endometrial tumors to shrink and to see if this treatment is safe.. Eligibility:. - Adults age 18-70 with metastatic digestive tract, ...
https://clinicaltrials.gov/ct2/show/study/NCT01174121?show_desc=Y
*  Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer -...
Ovarian Endometrioid Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Surface Papillary Adenocarcinoma Pancreatic ... Adenocarcinoma, Papillary. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Endocrine Gland Neoplasms. ... Adenocarcinoma. Ovarian Neoplasms. Carcinoma, Hepatocellular. Fallopian Tube Neoplasms. Neuroendocrine Tumors. Carcinoid Tumor ... Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma Endometrial Serous Adenocarcinoma Localized Non- ...
https://clinicaltrials.gov/ct2/show/NCT01010126?cond=%22Liver+Neoplasms%22&rank=19
*  Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy - Full Text View - ClinicalTrials.gov
Treatment with novel radiotherapeutic technologies could increase local control in adenoid cystic carcinoma of the head and neck. Especially combined treatment with intensity-modulated radiation therapy and heavy ion (C12) boost to the primary tumor or previous tumor bed could be established as the treatment of choice in this disease.. Unfortunately, therapeutic results in the treatment of adenoid cystic carcinoma are still hampered by the occurrence of distant metastases (predominantly in the lungs) which, though progressing comparatively slowly, still limit the patient's life expectancy. Most adenoid cystic carcinomas (, 80%) though, exhibit over-expression of EGFR receptors and hence provide an approach for systemic treatment. In this prospective phase II trial, the application of the EGFR antibody cetuximab will be evaluated in combination with the established treatment of intensity-modulated radiation therapy plus C12 heavy ion boost.. The trial aims at evaluation of toxicity and ...
https://clinicaltrials.gov/ct2/show/NCT01192087?cond=%22Adenoid+cystic+carcinoma%22&rank=14
*  A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. - Full Text View - ClinicalTrials.gov
Adenocarcinoma. Kidney Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Kidney Diseases. Urologic ...
https://clinicaltrials.gov/ct2/show/NCT01206764
*  Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer - Full Text View -...
Adenocarcinoma. Neuroendocrine Tumors. Neuroectodermal Tumors. Neoplasms, Germ Cell and Embryonal. Neoplasms, Ductal, Lobular, ... Adenocarcinoma, Follicular. Carcinoma, Medullary. Carcinoma, Neuroendocrine. Neoplasms, Glandular and Epithelial. Neoplasms by ...
https://clinicaltrials.gov/ct2/show/NCT00118248
*  Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer - Full Text View -...
Adenocarcinoma. Neoplasms, Ductal, Lobular, and Medullary. Breast Carcinoma In Situ. Oxytocin. Oxytocics. Reproductive Control ...
https://clinicaltrials.gov/ct2/show/study/NCT02127073